WIPF3 rabbit pAb
Product details
Background:
Specifications
| Size | 50μL/100μL |
| Target | WIPF3 |
| Reactivity | Human, Mouse, Rat |
| Applications | WB |
| MW(Calculated) | 53kD |
| MW(Observed) | |
| Host Species | Rabbit |
| Isotype | IgG |
| Conjugate/Modification | Unmodified |
| Recommended Dilution Ratio | WB 1:500-2000 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Storage | -15°C to -25°C/1 year(Do not lower than -25°C) |
| Concentration | 1 mg/ml |
| Clonality | Polyclonal |
| Clone Number | |
| Immunogen | Synthesized peptide derived from human WIPF3 AA range: 66-116 |
| Specificity | This antibody detects endogenous levels of WIPF3 at Human/Mouse/Rat |
| Gene Name | WIPF3 CR16 |
| Protein Name | WIPF3 |
| Other Name | |
| Species | Human |
| Gene ID | |
| Uniprot | A6NGB9, |
| Species.1 | Mouse |
| Gene ID.1 | |
| Uniprot.1 | P0C7L0, |
| Species.2 | Rat |
| Gene ID.2 | 259242 |
| Uniprot.2 | Q9Z0G8 |
| Cellular Localization | Cytoplasm. In hippocampal neurons colocalizes with WASL in the cell body, axons and the growth cone. . |
| Tissue Expression | |
| Signaling_pathway | |
| Research Areas | >>Endocytosis; / >>Pathogenic Escherichia coli infection; / >>Yersinia infection |
| Function | Domain:The KLKR motif is essential for G-actin binding and for actin polymerization.,Domain:The profilin-binding motif has been implicated in the interaction with profilin and SH3 domains.,Domain:The WH2 domain is found in a number of putative actin-binding proteins.,Function:May be a regulator of cytoskeletal organization. May have a role in spermatogenesis.,similarity:Belongs to the verprolin family.,similarity:Contains 1 WH2 domain.,subcellular location:In hippocampal neurons colocalizes with WASL in the cell body, axons and the growth cone.,subunit:Interacts with WASL, and monomeric and filamentous actin., |
Please login to post questions






